Abstract:BACKGROUND:Nasopharyngeal carcinoma (NPC) is a common malignancy in China and Southeast Asia. Radiotherapy is the major treatment modality for patients with NPC, but does not always achieve fully satisfactory outcomes. Studies have shown that epidermal growth factor receptor (EGFR) is highly expressed in NPC, and EGFR-targeted treatment is expected to be a new strategy for NPC. Recently, clinical trials have shown that NPC patients have different responses to gefitinib. Thus, the identification of indicators that can regulate and predict the sensitivity of NPC to gefitinib is very valuable. MiRNAs (MicroRNAs) are closely related to cancer development. We studied miRNAs in NPC cell lines to identify those that can regulate and predict the effectiveness of gefitinib on NPC.METHODS:CCK8, Annexin V-FITC assays and animal models were carried out to evaluate the inhibitory effect of gefitinib on NPC cell lines HNE-1 and HK-1. MiRNA microarrays were used to detect and compare the miRNAs expression levels in the two cells with gefitinib or not, and qRT-PCR was used to evaluate miR-125a-5p expression in NPC cells and in serum of the tumor animal models. Loss-of-function and gain-of-function experiments were taken to evaluate the effect of miR-125a-5p on gefitinib effectiveness. Western blots were used to evaluate the effect of miR-125a-5p on p53 and Her2 in HNE-1 and HK-1 cells.RESULTS:Gefitinib inhibited two NPC cell lines proliferation in vitro and in vivo,and HNE-1 cells were less sensitive than HK-1 cells to gefitinib.MiR-125a-5p expression levels were increased by geftinib in the two cell lines and in the serum of NPC tumor bearing-mice. This phenomenon was weak in HNE-1 cells and strong in HK-1 cells. MiR-125a-5p over expression improved anti-proliferative and pro-apoptotic effects of gefitinib on the NPC cells and that miR-125a-5p down-regulation decreased those effects. MiR-125a-5p also increased p53 protein expression in HNE-1 cells, and decreased Her2 protein expression in HNE-1 and HK-1 cells.CONCLUSIONS:Our results indicate that gefitinib sensitivity and some miRNAs expressions varied in NPC cell lines. The miR-125a-5p is a possible candidate that can regulate and predict the effect of gefitinib on NPC.

miR-1254 induced by NESG1 inactivates HDGF/DDX5-stimulated nuclear translocation of β-catenin and suppresses NPC metastasis

MiRNA-125a-5p: a Regulator and Predictor of Gefitinib's Effect on Nasopharyngeal Carcinoma.

FOXA1 Suppresses the Growth, Migration, and Invasion of Nasopharyngeal Carcinoma Cells Through Repressing Mir-100-5p and Mir-125B-5p.

MiR-124 suppresses tumor growth and metastasis by targeting Foxq1 in nasopharyngeal carcinoma

The CBP/β-Catenin Antagonist, ICG-001, Inhibits Tumor Metastasis via Blocking of the miR-134/ITGB1 Axis-Mediated Cell Adhesion in Nasopharyngeal Carcinoma

miR-200a-mediated downregulation of ZEB2 and CTNNB1 differentially inhibits nasopharyngeal carcinoma cell growth, migration and invasion.

MicroRNA-483-5p Predicts Poor Prognosis and Promotes Cancer Metastasis by Targeting EGR3 in Nasopharyngeal Carcinoma

LncRNA SNHG16 Facilitates Nasopharyngeal Carcinoma Progression by Acting As Cerna to Sponge Mir-520A-3p and Upregulate MAPK1 Expression

TGF-β Regulates the ERK/MAPK Pathway Independent of the SMAD Pathway by Repressing Mirna-124 to Increase MALAT1 Expression in Nasopharyngeal Carcinoma

MiR-125b Regulates Proliferation and Apoptosis of Nasopharyngeal Carcinoma by Targeting A20/NF-κB Signaling Pathway

Mir-145 Inhibits Metastasis By Targeting Fascin Actin-Bundling Protein 1 In Nasopharyngeal Carcinoma

EZH2-DNMT1-mediated Epigenetic Silencing of Mir-142-3p Promotes Metastasis Through Targeting ZEB2 in Nasopharyngeal Carcinoma

TGF-? regulates the ERK/MAPK pathway independent of the SMAD pathway by repressing miRNA-124 to increase MALAT1 expression in nasopharyngeal carcinoma.

miR-185-3p regulates the invasion and metastasis of nasopharyngeal carcinoma by targeting WNT2B in vitro .

MicroRNA-18a Promotes Cancer Progression Through SMG1 Suppression and Mtor Pathway Activation in Nasopharyngeal Carcinoma.

LncRNA FOXP4-AS1 Silencing Inhibits Metastasis and Epithelial–mesenchymal Transition in Nasopharyngeal Carcinoma Via Mir-136-5p/mapk1

MiR‐2110 induced by chemically synthesized cinobufagin functions as a tumor‐metastatic suppressor via targeting FGFR1 to reduce PTEN ubiquitination degradation in nasopharyngeal carcinoma

Downregulation of MicroRNA-1 and Its Potential Molecular Mechanism in Nasopharyngeal Cancer: An Investigation Combined with In Silico and In-House Immunohistochemistry Validation

CDC42-interacting Protein 4 Promotes Metastasis of Nasopharyngeal Carcinoma by Mediating Invadopodia Formation and Activating EGFR Signaling

Mir-324-3p Suppresses Migration and Invasion by Targeting WNT2B in Nasopharyngeal Carcinoma.

MicroRNA-1243 p inhibits the growth and metastasis of nasopharyngeal carcinoma cells by targeting STAT 3